European Commission Approves PREZISTA(R) (darunavir) 800 mg Tablet Once a Day Reducing the Number of Pills Taken by People Living With HIV

CORK, Ireland, January 16, 2013 (HSMN NewsFeed) --Janssen R&D Ireland announced today that the European Commission (EC) has approved a new PREZISTA® (darunavir) 800mg tablet allowing people living with HIV to take one darunavir tablet once a day. Dar... Biopharmaceuticals, HIV/AIDS, RegulatoryJanssen, PREZISTA, darunavir
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news